Metabolic
Exenatide
Exendin-4 / Byetta / Bydureon
- Peptide length
- 39 amino acids
Exendin-4 peptide
Research contextDefined therapeutic evidence
Read the linked studies for their methods and limitations.
A GLP-1 receptor agonist used in diabetes medicines with immediate-release and extended-release formulations.
- Family
- Exendin-derived incretin agonist
- Research frame
- GLP-1 receptor
- Molecular format
- Exendin-4 peptide
Read the evidence
Formulation determines exposure and administration characteristics. Evidence and labeling for one product do not automatically transfer to another.
Resolve the identity
Distinguish the active peptide from its depot formulation and confirm terminal amidation.